Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Heart Failure and Cardiomyopathy: From Bench to Bedside
  • Clinical
  • Share Icon
    Bookmark Icon
  • A Phase I, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of N-acetylgalactosamine Small Interfering RNA Conjugate, BPR-30221616, in Healthy Participants, for Potential Treatment of Transthyretin Amyloidosis
    • Schedule
    Notes
  • Clinical Science Zone 2‚ Moderated Digital Poster 22
    HF.MDP.33
    Set Timezone
Generic 'disconnected' Message

Presentation ID: MP973

4365285

Disclosures:
langxi zhang: Financial relationships have not been disclosed at this time. | haoxi huang: Financial relationships have not been disclosed at this time. | shengjun fan: Financial relationships have not been disclosed at this time. | Xiaohong Han: Financial relationships have not been disclosed at this time. | Rui Chen: Financial relationships have not been disclosed at this time. |

Communities
Navigation
Program Selection
Session Type
Main Session